Unterscheidet sich das zervikale CUP Syndrom immunhistologisch vom Oropharynxkarzinom?
Markus Wirth(Technical University of Munich), Anja Pickhard(TUM Klinikum), K Feigl(TUM Klinikum), Barbara Wollenberg(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Michael Siegl(Technical University of Munich), Felix Johnson(TUM Klinikum), Kim-Aylin Voßenkämper(Technical University of Munich), Melanie Boxberg(Starnberg Hospital)
Cited by 0
Related Papers
Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system
|Histopathology|2017|105
PD-L1 and PD-1 and characterization of tumor-infiltrating lymphocytes in high grade sarcomas of soft tissue – prognostic implications and rationale for immunotherapy
|OncoImmunology|2017|89
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II
|Annals of Oncology|2018|83
Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma
|The Journal of Immunology|2018|81
Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix
|The Journal of Pathology Clinical Research|2018|80